Institutions as Enablers of Science-Based Industries

Biotechnology impacts across different industrial uses of the life sciences, and has acquired a relevant role in addressing challenges faced by world economies such as those related to food, water, energy and healthcare provision. Many governments in emerging economies looking to exploit some of the opportunities provided by advances in biotechnology design institutional frameworks to cope and develop this complex science-based industry. In this context, a country´s science, technology and innovation institutional structure plays a key role in shaping the outcomes, commercialization, investments, and alliance strategies of this particular industry. This chapter builds on the innovation systems perspective to describe how institutions act as enabling factors for innovation and research in biotechnology. These factors are, as defined by the Biotechnology Industry Organization, infrastructure for R&D, human capital, intellectual property protection, regulatory environment, technology transfer frameworks, market, and commercial incentives.

Institutions as Enablers of Science-Based Industries

Biotechnology impacts across different industrial uses of the life sciences, and has acquired a relevant role in addressing challenges faced by world economies such as those related to food, water, energy and healthcare provision. Many governments in emerging economies looking to exploit some of the opportunities provided by advances in biotechnology design institutional frameworks to cope and develop this complex science-based industry. In this context, a country´s science, technology and innovation institutional structure plays a key role in shaping the outcomes, commercialization, investments, and alliance strategies of this particular industry. This chapter builds on the innovation systems perspective to describe how institutions act as enabling factors for innovation and research in biotechnology. These factors are, as defined by the Biotechnology Industry Organization, infrastructure for R&D, human capital, intellectual property protection, regulatory environment, technology transfer frameworks, market, and commercial incentives.

Institutions as Enablers of Science-Based Industries

Biotechnology impacts across different industrial uses of the life sciences, and has acquired a relevant role in addressing challenges faced by world economies such as those related to food, water, energy and healthcare provision. Many governments in emerging economies looking to exploit some of the opportunities provided by advances in biotechnology design institutional frameworks to cope and develop this complex science-based industry. In this context, a country´s science, technology and innovation institutional structure plays a key role in shaping the outcomes, commercialization, investments, and alliance strategies of this particular industry. This chapter builds on the innovation systems perspective to describe how institutions act as enabling factors for innovation and research in biotechnology. These factors are, as defined by the Biotechnology Industry Organization, infrastructure for R&D, human capital, intellectual property protection, regulatory environment, technology transfer frameworks, market, and commercial incentives.

Advances in drug development & approvals landscape, and industry partnerships

The Biotechnology Industry Organization (BIO) held its 2014 Annual Convention at the San Diego Convention Center, CA (June 23-26, 2014). This event was attended by more than 15,660 industry leaders that included 2,500 Chief Executive Officers (CEOs), several U.S. Governors, and ­representatives from 50 states and 70 countries. The BIO Exhibition saw presence of over 1,800 exhibitors with 55 state and international pavilions. Additional features of the Convention comprised 192 company presentations, 800 speakers and 160 sessions in 9 specialty forums and 8 educational tracks and 29,000+ one-on-one partnering meetings between 3,100+ ­companies. Keynote speakers featured Sir Richard Branson and Former Secretary of State Hillary Rodham Clinton.Â